A simple idea, executed elegantly.

In the NEJM TRIDENT trial, a single low-dose triple antihypertensive pill reduced recurrent stroke after intracerebral hemorrhage (HR 0.61) and improved BP control (50% vs 26%).

Yet, only half reached target—reminding us that pills alone don't solve therapeutic inertia.

The message is clear: simplify treatment, intensify targets, and build systems that ensure control.

One pill helps. Systems save lives. 💊📉🧠